Hadassah

Patient Number Three Saved at Hadassah with World-First Stem Cell Treatment

Thursday, Sep 27 2012

With a world-first placental stem-cell (PLX) treatment, developed by Pluristem, doctors at the Hadassah University Medical Center have saved the life of a third patient suffering from bone marrow disease.

"Following three successful treatments, which were conducted for the first time in the world at the Hadassah Medical Center,” relates Prof. Reuven Or, Director of Hadassah’s Bone Marrow Transplantation and Cancer Immunology Department, “we can say that PLX cells from the placenta saved the life of patients suffering from bone marrow failure. We are very encouraged by the results and hope that future clinical trials will show the effectiveness of the PLX cells. I believe that the PLX treatment holds huge hope for patients who suffer from different conditions of bone marrow failure and, once approved, will be available for every patient who needs it.”

This most recent patient, a 45-year-old man who has acute myeloid leukemia, a form of blood cancer, had undergone chemotherapy and an unrelated bone marrow transplant, but still suffered from a life-threatening shortage of white blood cells. After receiving two intramuscular injections of the placental stem cells, one week apart, his clinical condition and overall well being improved significantly enough for him to be released from the hospital.

In addition to helping the three patients, Pluristem Chief Executive Officer Zami Aberman notes, the data suggests that the PLX cells may be helpful in rescuing both bone marrow transplant failures that were allogeneic (genetically different) as well as autologous (from the patient’s own cells).

 


Read more on Hadssah's Stem Cell Treatment

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Monday, Dec 10 2018

A Nurses Council Celebration in Israel: The Milestone Mission

We were honored to meet so many dynamic Hadassah nurses, some longtime and some new members--all of us excited to be together to celebrate the 100th anniversaries of the Hadassah Medical Organization, the Henrietta Szold Hadasssah-Hebrew University Nursing School and HMO's Department of Ophthalmology. And Israel's 70th

READ MORE ›
alt_text

Wednesday, Dec 5 2018

Prof. Chowers’ Long and Meaningful Hadassah Connections

Sophie Szold, mother of Hadassah founder Henrietta, wept when she saw children with flies in their eyes on their maiden trip to pre-state Israel in 1909. Those children had trachoma, endemic in the Middle East in those days.

READ MORE ›
alt_text

Wednesday, Dec 5 2018

Ending the Violence Against Women: Hadassah Staff Joins Nationwide Protests

On December 4, employees from both Hadassah Hospital Ein Kerem and Hadassah Hospital Mount Scopus rallied to end violence against women. “Together we will banish the darkness and return the light to all women,” read banners held by the participants.

READ MORE ›
alt_text

Tuesday, Dec 4 2018

No Ovaries? Mystery Solved By Hadassah Endocrinologist

A few years ago, a mother brought her teenage daughter to see Prof. David Zangen, Director of Pediatric Endocrinology at the Hadassah Medical Organization.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More